Literature DB >> 17534465

More medications, fewer pills: combination medications for the treatment of hypertension.

Richard Lewanczuk1, Sheldon W Tobe.   

Abstract

Achieving blood pressure targets in hypertension can be challenging. Often, patients require multiple medications to reach these targets. The Canadian Hypertension Education Program has updated its past recommendations to reflect current knowledge regarding effective antihypertensive combinations. Evidence for the use of specific drug combinations in achieving blood pressure targets has been reviewed, and the inventory of effective drug combinations has been expanded. From a clinical perspective, fixed-dose antihypertensive combinations offer certain advantages in terms of efficacy, adherence, cost, convenience, patient-perceived 'wellness' and side effects. Consequently, in the future, fixed-dose combination formulations are likely to become increasingly used in the treatment of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534465      PMCID: PMC2650762          DOI: 10.1016/s0828-282x(07)70803-6

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  21 in total

1.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

2.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Authors:  N A Khan; Finlay A McAlister; Simon W Rabkin; Raj Padwal; Ross D Feldman; Norman Rc Campbell; Lawrence A Leiter; Richard Z Lewanczuk; Ernesto L Schiffrin; Michael D Hill; Malcolm Arnold; Gordon Moe; Tavis S Campbell; Carol Herbert; Alain Milot; James A Stone; Ellen Burgess; B Hemmelgarn; Charlotte Jones; Pierre Larochelle; Richard I Ogilvie; Robyn Houlden; Robert J Herman; Pavel Hamet; George Fodor; George Carruthers; Bruce Culleton; Jacques Dechamplain; George Pylypchuk; Alexander G Logan; Norm Gledhill; Robert Petrella; Sheldon Tobe; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

3.  Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes.

Authors:  J F Mateo; V F Gil-Guillén; E Mateo; D Orozco; J A Carbayo; J Merino
Journal:  Int J Clin Pract       Date:  2006-04       Impact factor: 2.503

4.  Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program.

Authors:  Jay Onysko; Colleen Maxwell; Michael Eliasziw; Jenny X Zhang; Helen Johansen; Norm R C Campbell
Journal:  Hypertension       Date:  2006-09-18       Impact factor: 10.190

5.  A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).

Authors:  William H Frishman; James W Hainer; Jennifer Sugg
Journal:  Am J Hypertens       Date:  2006-04       Impact factor: 2.689

6.  Drug utilization in the old old and how it relates to self-perceived health and all-cause mortality: results from the Bronx Aging Study.

Authors:  D L Hershman; P A Simonoff; W H Frishman; F Paston; M K Aronson
Journal:  J Am Geriatr Soc       Date:  1995-04       Impact factor: 5.562

7.  Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter?

Authors:  J Scholze; M Bida; A Hansen; D Juncken; B Rangoonwala; A Ritz; J Schnitker; Y Dörffel
Journal:  Int J Clin Pract       Date:  2006-03       Impact factor: 2.503

8.  The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

Authors:  Raj S Padwal; Brenda R Hemmelgarn; Finlay A McAlister; Donald W McKay; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael Hill; Jeff Mahon; Martin G Myers; Carl Abbott; Ernest L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Nadia A Khan; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

9.  Compliance with medication regimens among chronically ill, inner city patients.

Authors:  J Y Greene; M Weinberger; M J Jerin; J J Mamlin
Journal:  J Community Health       Date:  1982

10.  Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.

Authors:  Joel M Neutel; David H G Smith; Michael A Weber; Lesley Schofield; Das Purkayastha; Marjorie Gatlin
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-11       Impact factor: 3.738

View more
  5 in total

Review 1.  Novel platforms for oral drug delivery.

Authors:  P Colombo; F Sonvico; G Colombo; R Bettini
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

Review 2.  Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.

Authors:  Mohamed A Alhnan; Tochukwu C Okwuosa; Muzna Sadia; Ka-Wai Wan; Waqar Ahmed; Basel Arafat
Journal:  Pharm Res       Date:  2016-05-18       Impact factor: 4.200

Review 3.  What factors contribute to the inadequate control of elevated blood pressure?

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

Review 4.  Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Vasc Health Risk Manag       Date:  2008

5.  The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes.

Authors:  Sieta T de Vries; Folgerdiena M de Vries; Thijs Dekker; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Adelita V Ranchor; Petra Denig
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.